Symptomatic intracranial atherosclerotic stenosis (sICAS), typically defined as an ischemic
stroke or transient ischemic attack associated with a proximal 50% to 99% stenosis of a …

The stenting versus aggressive medical therapy for intracranial artery stenosis (SAMMPRIS)
trial compared aggressive medical therapy to aggressive medical therapy and percutaneous …

Objective There are few data regarding the effect of the Stenting and Aggressive Medical
Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial …

Background The risk of early recurrence in medically treated patients with intracranial
atherosclerotic stenosis (ICAS) may differ in clinical trials versus real-world settings. Delayed …

S42 Stroke June 2013 than anterior circulation, 9 posterior circulation stenosis did not
respond better to warfarin than aspirin, 9 and patients already on antithrombotic medication …

Intracranial atherosclerotic stenosis (ICAS) is one of the most frequent causes of stroke
worldwide and confers one of the greatest risks of recurrent stroke compared with other …

Background: Symptomatic intracranial atherosclerotic stenosis (sICAS) is one of the
common causes of ischemic stroke. However, the treatment of sICAS remains a challenge in …

The Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and
Intracranial Stenosis (SAMMPRIS) trial, a randomized clinical trial comparing aggressive …

Intracranial atherosclerotic disease (ICAD) accounts for 33–50% of all ischemic strokes in
the Asian population (1) and represents an important public health issue in China. The …

Percutaneous transluminal angioplasty and stent placement (PTAS) has become a
treatment option for selected patients with symptomatic intracranial arterial stenosis. 1 The …